{
    "news_source": "dw",
    "news_id": "dw_a71524627",
    "news_header": "Ebola continues to pose challenges, but vaccine development may alleviate its impact.",
    "news_original_title": "Ebola explained: Symptoms, treatment and vaccines",
    "news_text": "Ebola remains a significant challenge in affected regions, primarily caused by the Zaire and Sudan types of the virus. Recent outbreaks have allowed researchers to test vaccines, with notable outbreaks occurring between 2014-2016 and 2018-2020, resulting in thousands of infections and deaths. Treatments include antibody-based drugs like Ebanga and Inmazeb, and the vaccine Ervebo, which is approved in the US and EU. A new trial for a Sudan virus vaccine has also been launched in Uganda.",
    "news_url": "https://www.dw.com/en/ebola-explained-symptoms-treatment-and-vaccines/a-71524627",
    "news_time": 1738847220.0,
    "news_categories": [
        "science"
    ],
    "news_source_lang": "en",
    "news_group": -1
}